文献速递呼吸衰竭与机械通气

肺栓塞与COVID-19:不同诊断模型性能的比较分析

Pulmonary embolism and COVID-19: A comparative analysis of different diagnostic models performance.
PubMed 文献 · Am J Emerg Med · 2021-09-20
一句话结论在COVID-19患者中,Wells、Geneva、YEARS和PEGeD等诊断预测规则均不能可靠预测肺栓塞,数据支持使用500 ng/mL的D-二聚体阈值。

这项回顾性研究纳入300例因怀疑肺栓塞而接受CTPA的COVID-19急诊患者,肺栓塞确诊率为15%。Wells和Geneva评分(无论标准或年龄调整cut-off)对肺栓塞发生均无预测价值。YEARS和PEGeD算法虽提高特异性(减少19%的CTPA),但增加漏诊肺栓塞。肺栓塞患者D-二聚体水平更高,但提高阈值筛选CTPA会大幅降低敏感性。结论:在COVID-19患者中,没有诊断预测规则是可靠的肺栓塞预测因子。

要点

  • 在COVID-19患者中,Wells和Geneva评分(标准或年龄调整cut-off)对肺栓塞均无预测价值。
  • YEARS和PEGeD算法可提高特异性并减少19%的CTPA,但会增加未诊断的肺栓塞。
  • 肺栓塞患者D-二聚体水平高于无肺栓塞者,但提高D-二聚体阈值筛选CTPA会大幅降低敏感性。
  • 数据支持在COVID-19疑似肺栓塞患者中使用500 ng/mL的D-二聚体阈值,而非更高阈值。
  • 该研究为单中心回顾性设计,样本量300例,结论需前瞻性验证。

适用人群与场景

  • 因怀疑肺栓塞而接受CTPA的COVID-19急诊患者。
  • 研究为单中心回顾性研究,纳入连续入急诊的COVID-19患者。

诊断标准与关键阈值

  • 肺栓塞诊断预测规则包括:Wells评分、Geneva评分(标准cut-off及年龄调整cut-off)、YEARS算法、PEGeD算法。
  • D-二聚体标准cut-off为500 ng/mL。
  • 原文未提及各评分具体的界值或启动/停止阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及红旗征或不能漏诊的具体情况。

研究设计与关键结果

  • 研究类型:单中心回顾性研究,纳入300例因怀疑肺栓塞接受CTPA的COVID-19急诊患者,肺栓塞确诊率15%。
  • 有与无肺栓塞患者在合并症、传统肺栓塞危险因素及症状体征方面无差异。
  • Wells和Geneva评分(标准或年龄调整cut-off)对肺栓塞发生无预测价值。
  • YEARS和PEGeD算法提高特异性(减少19%的CTPA),但增加未诊断的肺栓塞。
  • 肺栓塞患者D-二聚体水平更高,但提高阈值筛选CTPA会大幅降低敏感性。

证据类型、等级与局限

  • 证据类型:单中心回顾性研究。
  • 局限:回顾性设计、单中心、样本量300例,结论需前瞻性验证。

对床旁实践的改变

  • 在COVID-19疑似肺栓塞患者中,不应依赖Wells或Geneva评分来决定是否行CTPA。
  • 使用YEARS或PEGeD算法提高特异性减少CTPA时,需警惕漏诊肺栓塞的风险。
  • 数据支持使用500 ng/mL的D-二聚体阈值,提高阈值虽增加特异性但会大幅降低敏感性,限制其作为筛查测试的可靠性。
  • 该结论基于单中心回顾性研究,适用人群为因怀疑肺栓塞接受CTPA的COVID-19急诊患者,不适用于非COVID-19患者。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: Pulmonary embolism (PE) is a common complication of SARS-CoV-2 infection. Several diagnostic prediction rules based on pretest probability and D-dimer have been validated in non-COVID patients, but it remains unclear if they can be safely applied in COVID-19 patients. We aimed to compare the diagnostic accuracy of the standard approach based on Wells and Geneva scores combined with a standard D-dimer cut-off of 500 ng/mL with three alternative strategies (age-adjusted, YEARS and PEGeD algorithms) in COVID-19 patients.

METHODS: This retrospective study included all COVID-19 patients admitted to the Emergency Department (ED) who underwent computed tomography pulmonary angiography (CTPA) due to PE suspicion. The diagnostic prediction rules for PE were compared between patients with and without PE.

RESULTS: We included 300 patients and PE was confirmed in 15%. No differences were found regarding comorbidities, traditional risk factors for PE and signs and symptoms between patients with and without PE. Wells and Geneva scores showed no predictive value for PE occurrence, whether a standard or an age-adjusted cut-off was considered. YEARS and PEGeD algorithms were associated with increased specificity (19% CTPA reduction) but raising non-diagnosed PE. Despite elevated in all patients, those with PE had higher D-dimer levels. However, incrementing thresholds to select patients for CTPA was also associated with a substantial decrease in sensitivity.

CONCLUSION: None of the diagnostic prediction rules are reliable predictors of PE in COVID-19. Our data favour the use of a D-dimer threshold of 500 ng/mL, considering that higher thresholds increase specificity but limits this strategy as a screening test.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Silva BV, Jorge C, Plácido R, et al. Pulmonary embolism and COVID-19: A comparative analysis of different diagnostic models performance. Am J Emerg Med. 2021. PMID: 34547695. doi:10.1016/j.ajem.2021.09.004

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。